NCT05992155View on ClinicalTrials.gov

A Study of TAK-279 in Adults With or Without Kidney Problems

PHASE1CompletedINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

September 27, 2023

Primary Completion Date

May 22, 2024

Study Completion Date

May 28, 2024

Conditions

Renal ImpairmentHealthy Volunteers

Interventions

DRUG

TAK-279

TAK-279 capsules.

Trial Locations (3)

32809

Orlando Clinical Research Center, Orlando

33014

Clinical Pharmacology of Miami, Miami

60643

Research by Design, Chicago

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Takeda

INDUSTRY